# SSRIs and TDCS Enhance Post-stroke Motor Recovery

> **NCT05041582** · PHASE3 · UNKNOWN · sponsor: **Chih-Wei Tang** · enrollment: 80 (estimated)

## Conditions studied

- Stroke
- Motor

## Interventions

- **DEVICE:** tDCS
- **DRUG:** Citalopram
- **BEHAVIORAL:** Rehabilitation

## Key facts

- **NCT ID:** NCT05041582
- **Lead sponsor:** Chih-Wei Tang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041582, "SSRIs and TDCS Enhance Post-stroke Motor Recovery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05041582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*